Results 231 to 240 of about 9,940,766 (374)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

A randomized trial of grant writing coaching groups: Baseline analysis of early-career scientists' research background, demographics, and mentorship variables. [PDF]

open access: yesPLoS One
Weber-Main AM   +9 more
europepmc   +1 more source

Ancient DNA and human history

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2016
M. Slatkin, F. Racimo
semanticscholar   +1 more source

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis

open access: yesMolecular Oncology, EarlyView.
This study highlights the potential of automated enumeration using the ACCEPT software to refine circulating tumor cell (CTC) detection in metastatic colorectal cancer (mCRC). The automated method demonstrates improved accuracy and reduced variability compared to the manual approach.
Michela De Meo   +6 more
wiley   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

A multi-society Delphi consensus statement on the diagnosis of familial chylomicronemia syndrome. [PDF]

open access: yesArch Endocrinol Metab
Aguilar-Salinas CA   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy